IL62833A - Dna sequences,recombinant dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens - Google Patents

Dna sequences,recombinant dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens

Info

Publication number
IL62833A
IL62833A IL62833A IL6283381A IL62833A IL 62833 A IL62833 A IL 62833A IL 62833 A IL62833 A IL 62833A IL 6283381 A IL6283381 A IL 6283381A IL 62833 A IL62833 A IL 62833A
Authority
IL
Israel
Prior art keywords
specificity
foot
processes
mouth disease
viral antigens
Prior art date
Application number
IL62833A
Other languages
English (en)
Other versions
IL62833A0 (en
Original Assignee
Biogen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Nv filed Critical Biogen Nv
Publication of IL62833A0 publication Critical patent/IL62833A0/xx
Publication of IL62833A publication Critical patent/IL62833A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL62833A 1980-05-12 1981-05-11 Dna sequences,recombinant dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens IL62833A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8015635 1980-05-12
GB8026661 1980-08-15

Publications (2)

Publication Number Publication Date
IL62833A0 IL62833A0 (en) 1981-07-31
IL62833A true IL62833A (en) 1984-12-31

Family

ID=26275483

Family Applications (1)

Application Number Title Priority Date Filing Date
IL62833A IL62833A (en) 1980-05-12 1981-05-11 Dna sequences,recombinant dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens

Country Status (15)

Country Link
EP (1) EP0040922A1 (de)
AU (1) AU547096B2 (de)
BR (1) BR8102922A (de)
DD (1) DD160279A5 (de)
DK (1) DK207681A (de)
ES (2) ES8304204A1 (de)
GR (1) GR74523B (de)
IE (1) IE51178B1 (de)
IL (1) IL62833A (de)
IN (1) IN156358B (de)
NO (1) NO811609L (de)
PL (1) PL231111A1 (de)
PT (1) PT73021B (de)
YU (1) YU120581A (de)
ZW (1) ZW11281A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL62553A (en) * 1980-06-06 1984-12-31 Biogen Nv Vectors comprising dna sequences comprising at least one promoter and operator derived from bacteriophage ypsilon and methods for producing such recombinant dna molecules and cloning vectors
US4874702A (en) * 1980-09-08 1989-10-17 Biogen, Inc. Vectors and methods for making such vectors and for expressive cloned genes
NL8104297A (nl) * 1980-09-18 1982-04-16 Wellcome Found Dna-moleculen met polynucleotidevolgordes die geheel of ten dele overeenkomen met mond- en klauwzeervirus rna, alsmede werkwijze ter bereiding daarvan.
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
GB2103622B (en) * 1981-06-16 1986-01-15 Genentech Inc Production of foot and mouth disease vaccine from microbially expressed antigens
ZA831854B (en) * 1982-03-26 1984-01-25 Biogen Nv Small peptides with the specificity of foot and mouth disease viral antigens
US4751083A (en) * 1982-05-06 1988-06-14 Massachusetts Institute Of Technology Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
US5230888A (en) * 1982-05-06 1993-07-27 Massachusetts Institute Of Technology Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
EP0105481A1 (de) * 1982-09-30 1984-04-18 The Wellcome Foundation Limited Antigene und diese enthaltende Vakzine
AU573574B2 (en) * 1983-03-08 1988-06-16 Chiron Mimotopes Pty Ltd Immunogenic deteminants of foot and mouth disease virus
WO1984003506A1 (en) * 1983-03-08 1984-09-13 Commw Serum Lab Commission Antigenically active amino acid sequences
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
BE901119A (fr) * 1984-11-23 1985-03-15 Wallone Region Procede de preparation de plasmides vecteurs capables de transformer un hote bacterien escherichia coli et d'y promouvoir et controler l'expression d'un adn heterologue.
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4732971A (en) * 1985-06-03 1988-03-22 Eli Lilly And Company Synthetic vaccines for foot and mouth disease
US6479787B1 (en) 1999-10-05 2002-11-12 Rexam Ab Laser unit and method for engraving articles to be included in cans

Also Published As

Publication number Publication date
IN156358B (de) 1985-07-06
PL231111A1 (en) 1983-07-18
PT73021B (en) 1983-10-19
AU547096B2 (en) 1985-10-03
DK207681A (da) 1981-11-13
ZW11281A1 (en) 1982-04-21
IL62833A0 (en) 1981-07-31
ES502089A0 (es) 1982-12-16
BR8102922A (pt) 1982-02-02
IE51178B1 (en) 1986-10-29
AU7045581A (en) 1981-12-10
GR74523B (de) 1984-06-29
EP0040922A1 (de) 1981-12-02
NO811609L (no) 1981-11-13
ES8307298A1 (es) 1983-06-16
ES8304204A1 (es) 1983-02-16
ES511491A0 (es) 1983-06-16
PT73021A (en) 1981-06-01
DD160279A5 (de) 1983-05-25
YU120581A (en) 1984-04-30
IE811049L (en) 1981-11-12

Similar Documents

Publication Publication Date Title
IL62833A (en) Dna sequences,recombinant dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens
PL229123A1 (en) Dna sequences,molecules of dna recombinants and methodsof preparing the polypeptides resembling the human interferon
ZA831854B (en) Small peptides with the specificity of foot and mouth disease viral antigens
IL67961A0 (en) Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
PH25120A (en) Replicable expression vehicle and process of preparation thereof
ZA81103B (en) Dna sequences ,recombinant dna molecules dna molecules and processes for producing human interferon -like polypeptides
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
EP0347435A4 (en) Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins
IL70856A0 (en) Dna sequences,recombinant dna molecules and processes for producing human interleukin two-like polypeptides
GB2079288B (en) Dna sequences recombinat dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens
GB2068970B (en) Recombinant dna technique for the preparation of a protein resembling human interferon
IL69514A0 (en) Recombinant dna molecules,process for their production,their use for production of hepatitis b surface antigen(hbsag)and pharmaceutical compositions containing this hbsag
ZA813110B (en) Dna sequences, recombinant dna molecules and processes for producing polypedtides with the specificity of foot and mouth disease viral antigens
EP0154587A3 (en) Fragments of dna which encode peptides capable of inducing in vivo the synthesis of anti-hepatitis a virus antibodies
ZA84512B (en) Dna sequences,recombinant dna molecules and processes for producing human interleukin two-like polypeptides
IL77830A (en) Dna sequences, recombinant dna molecules and processes for producing human b-interferon
EP0460674A3 (en) Recombinant dna and process for the production of chimaeric antibodies
KE3669A (en) Dna sequences,recombinant dna molecules and processes for producing human interferon-alpha like polypeptides
ATA71388A (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung
HRP921091B1 (en) Dna sequences, recombinant dna molecules and processes for producing human fibroplast interferon-like polypeptides
HRP940049B1 (en) Process for the preparation of recombinant dna molecules
TH1016A (th) การประดิษฐ์และการใช้กรดดีออกซีไรโบนิวคลีอิค(กรรมวิธี)
IE871743L (en) "dna sequence, recombinant dna molecules and process for¹producing the newcastle disease virus fusion protein or¹equivalent polypeptides, obtained products and preparations¹containing the same"